Your browser doesn't support javascript.
loading
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial.
Jones, T Hugh; Dobs, Adrian S; Randeva, Harpal; Moore, William; Parkin, Jacqueline M.
Affiliation
  • Jones TH; Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Trust, Barnsley, United Kingdom.
  • Dobs AS; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, United Kingdom.
  • Randeva H; Division of Endocrinology and Metabolism, The Johns Hopkins School of Medicine, Baltimore, MD, United States.
  • Moore W; Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
  • Parkin JM; Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM) and the Human Metabolism Research Unit (HMRU), Coventry, United Kingdom.
Eur J Endocrinol ; 189(3): 297-308, 2023 Sep 01.
Article in En | MEDLINE | ID: mdl-37579053

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypogonadism / Klinefelter Syndrome Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypogonadism / Klinefelter Syndrome Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido